ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth
- Posted by ISPE Boston
- On June 1, 2023
ElevateBio, LLC (ElevateBio), a technology-driven company focused on powering the creation of life-transforming cell and gene therapies, announced the closing of its $401 million Series D financing led by the AyurMaya Capital Management Fund, managed by Matrix Capital Management, and joined by a leading group of new and existing investors. ElevateBio’s syndicate now includes new […]
Read More